Cellcept and Primaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Primaxin (cilastatin sodium; imipenem). Common drug interactions include mucosal inflammation among females and hepatic artery stenosis among males.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Primaxin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Primaxin?

Primaxin has active ingredients of cilastatin sodium; imipenem. eHealthMe is studying from 4,540 Primaxin users. Check the latest studies of Primaxin.

On Jul, 12, 2026

26 people who take Cellcept and Primaxin together, and have interactions are studied.

Cellcept and Primaxin drug interactions.

What are the common drug interactions of Cellcept and Primaxin, by gender? *:

female:

Mucosal inflammation (infection of mucous membrane)
Rash
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Blood creatinine increased
Hepatic failure (liver failure)
Lower respiratory tract infection
Post procedural complication
Renal failure (kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)

male:

Hepatic artery stenosis (the abnormal narrowing of a hepatic artery)
Pleural effusion (water on the lungs)
Enterococcal infection
Sepsis (a severe blood infection that can lead to organ failure and death)
Thrombocytopenia (decrease of platelets in blood)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Biliary anastomosis complication (complication of biliary-enteric anastomosis (bea) is a common surgical procedure)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cholangitis (infection of the bile duct)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

What are the common drug interactions of Cellcept and Primaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abdominal pain
Blood creatinine increased
Blood triglycerides increased
Diarrhoea
Gamma-glutamyltransferase increased
Lower respiratory tract infection
Pancreatitis (inflammation of pancreas)
Pneumoperitoneum (air or gas in the abdominal (peritoneal) cavity)

10-19:

Bone marrow transplant rejection

20-29:

Hepatic failure (liver failure)
Post procedural complication
Renal failure (kidney dysfunction)

30-39:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Haemoglobin decreased
Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count decreased

40-49:

Thrombocytopenia (decrease of platelets in blood)
Blood creatinine increased
Septic shock (shock due to blood infection)

50-59:

Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Blood bilirubin increased
Diarrhoea
Enterococcal infection
Inflammation
Transplant rejection (a transplant material is not worked)
Deafness
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Acute respiratory failure
Biliary anastomosis complication (complication of biliary-enteric anastomosis (bea) is a common surgical procedure)

60+:

Mucosal inflammation (infection of mucous membrane)
Rash
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Gastrointestinal infection (infection of stomach and intestine)
Multi-organ failure (multisystem organ failure)
Polyomavirus-associated nephropathy (polyomavirus-associated kidney disease)
Urinary tract infection

What are the existing conditions these people have? *

Inflammation: 4 people, 15.38%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 15.38%
Blood Bilirubin Increased: 4 people, 15.38%
Infection: 3 people, 11.54%
Transplant Rejection (a transplant material is not worked): 2 people, 7.69%
Pain: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Primaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously